H
Helena Iznardo
Researcher at Autonomous University of Barcelona
Publications - 18
Citations - 149
Helena Iznardo is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Psoriasis. The author has an hindex of 4, co-authored 11 publications receiving 27 citations.
Papers
More filters
Journal ArticleDOI
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Helena Iznardo,Lluís Puig +1 more
TL;DR: In this paper, the IL-36 axis has been appointed a critical driver of the autoinflammatory responses involved in pustular psoriasis, and two IL36R blocking antibodies are currently undergoing phase II and III clinical trials, with promising results.
Journal ArticleDOI
Dual inhibition of IL-17A and IL-17F in psoriatic disease
Helena Iznardo,Lluís Puig +1 more
TL;DR: In this paper, a review of the current evidence on bimekizumab and sonelokimab targeting interleukin (IL)-17 cytokines is presented.
Journal ArticleDOI
Lentigo Maligna: Clinical Presentation and Appropriate Management.
TL;DR: Lentigo maligna has a very good prognosis, whereas LMM has the same prognosis as other invasive melanomas with similar Breslow thickness.
Journal ArticleDOI
The safety of brodalumab for the treatment of psoriasis
Helena Iznardo,Lluís Puig +1 more
TL;DR: Bdalumab is a highly efficacious and comparably safe therapeutic choice in patients with moderate to severe psoriasis, especially when rapid control of the disease is desired.
Journal ArticleDOI
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
Helena Iznardo,Lluís Puig +1 more
TL;DR: Treatment targeting of IL-1 pathways has been studied, and several monoclonal antibodies are currently being assessed in clinical trials, and promising results have been obtained with anti-IL-36R spesolimab and imsidolimAB in pustular psoriasis, and their efficacy is being tested in other conditions.